As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value.
Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.
This report shines a spotlight on:
- What’s driving the increased need for wound care.
- The potential effects of high-cost prescription wound dressings on patients and plan sponsors.
- How Optum Rx helps improve the quality of care while lowering costs.
Related healthcare insights
Article
Discover the benefits of outsourcing payment processes to a trusted leader.
Article
The collision of chronic conditions and behavioral health challenges can’t always be stopped, but healthcare leaders can work to mitigate its impact.
Article
Learn how payers can drive meaningful impact through preconception care, postpartum coaching and managing chronic conditions early.